Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
52 week high
|
Strong Performer, Getting Expensive
2550.0000
86.80
(
3.52
%)
NSE
Jul 07, 2026
15:31 PM
New 52W High today
Volume:
1.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
06 Aug 2025
52 week high
2550.00
3.52%
Result Update:Gland Pharma
Hold:
Gland Pharma Ltd.
by
Axis Direct
Target: 1950 | Target met
Target
Axis Direct
We maintain our HOLD rating on the stock with a target price of Rs 1,950/share.
Gland Pharma has gained
36.17%
in the last 1 Year
More from Gland Pharma Ltd.
Recommended
India's EV market grows beyond the early winners
The Baseline |
07 Jul 2026, 05:53PM
Market closes flat, dragged down by losses in metal & realty stocks
Trendlyne Marketwatch |
07 Jul 2026, 03:56PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020